FIGURE

Fig. 3

ID

ZDB-FIG-221113-3

Publication

Van Dycke et al., 2021 - A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Compound 4 and rupintrivir block the norovirus protease. (A) The FRET signal was lost upon co-transfection with the wild-type (WT) or a mutated protease (A105V, I109V, A105V/I109V). The signal remained upon co-transfection with the inactive (H30A) protease. (B) Western blot of HEK293T cells co-transfected with the GI, GII or GV WT or mutant proteases along with the FRET construct. Cleavage was observed in the WT and mutant proteases in all genogroups. EV: empty vector. (C) Dose–response curves of compound 4 and rupintrivir on the WT proteases. Mean values ±SEM are presented, Mann–Whitney test **** p < 0.0001, ns: not significant.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Viruses